lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: teva pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
teva pharmaceuticals, inc.
Dosage Form
TABLET, CHEWABLE
Routes
Active Ingredients
lisdexamfetamine dimesylate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0480-9739
Product ID
0480-9739_a9418850-010a-4fff-9aa7-d7167d58d8b6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215415
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2024-09-16
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04809739
Hyphenated Format
0480-9739
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA215415 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 100 TABLET, CHEWABLE in 1 BOTTLE (0480-9739-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a9418850-010a-4fff-9aa7-d7167d58d8b6", "openfda": {"upc": ["0304809739018", "0304809741011", "0304809744012", "0304809742018", "0304809738011", "0304809737014"], "unii": ["SJT761GEGS"], "rxcui": ["1871456", "1871460", "1871462", "1871464", "1871466", "1871468"], "spl_set_id": ["bdb03bfa-0398-41e5-8e73-ded696cbca32"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (0480-9739-01)", "package_ndc": "0480-9739-01", "marketing_start_date": "20240916"}], "brand_name": "lisdexamfetamine dimesylate", "product_id": "0480-9739_a9418850-010a-4fff-9aa7-d7167d58d8b6", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0480-9739", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lisdexamfetamine dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA215415", "marketing_category": "ANDA", "marketing_start_date": "20240916", "listing_expiration_date": "20261231"}